Mitochondria-Targeted Liposomes for Drug Delivery to Tumor Mitochondria
Pharmaceutics · 17.07.2024 · 16 (7) · 950
DOI: 10.3390/pharmaceutics16070950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 17.07.2024. Verfasst von Aysegul Ekmekcioglu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Sciences, Department of Medical Biotechnology, Acibadem Mehmet Ali Aydinlar University, 34752 Istanbul, Turkey. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Scientific and Technological Research Council of Turkey (TUBITAK), Scientific and Technological Research Council of Turkey (TUBITAK).
Abstract (Originalsprache)
The special bilayer structure of mitochondrion is a promising therapeutic target in the diagnosis and treatment of diseases such as cancer and metabolic diseases. Nanocarriers such as liposomes modified with mitochondriotropic moieties can be developed to send therapeutic molecules to mitochondria. In this study, DSPE-PEG-TPP polymer conjugate was synthesized and used to prepare mitochondria-targeted liposomes (TPPLs) to improve the therapeutic index of chemotherapeutic agents functioning in mitochondria and reduce their side effects. Doxorubicin (Dox) loaded-TPPL and non-targeted PEGylated liposomes (PPLs) were prepared and compared based on physicochemical properties, morphology, release profile, cellular uptake, mitochondrial localization, and anticancer effects. All formulations were spherically shaped with appropriate size, dispersity, and zeta potential. The stability of the liposomes was favorable for two months at 4 °C. TPPLs localize to mitochondria, whereas PPLs do not. The empty TPPLs and PPLs were not cytotoxic to HCT116 cells. The release kinetics of Dox-loaded liposomes showed that Dox released from TPPLs was higher at pH 5.6 than at pH 7.4, which indicates a higher accumulation of the released drug in the tumor environment. The half-maximal inhibitory concentration of Dox-loaded TPPLs and PPLs was 1.62-fold and 1.17-fold lower than that of free Dox due to sustained drug release, respectively. The reactive oxygen species level was significantly increased when HCT116 cells were treated with Dox-loaded TPPLs. In conclusion, TPPLs may be promising carriers for targeted drug delivery to tumor mitochondria.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Health Sciences, Department of Medical Biotechnology, Acibadem Mehmet Ali Aydinlar University, 34752 Istanbul, Turkey.
- Faculty of Engineering and Natural Sciences, Department of Biomedical Engineering, Acibadem Mehmet Ali Aydinlar University, 34752 Istanbul, Turkey.
- School of Medicine, Department of Biophysics, Acibadem Mehmet Ali Aydinlar University, 34752 Istanbul, Turkey.
- Faculty of Pharmacy, Department of Pharmaceutical Technology, Istanbul University, 34116 Istanbul, Turkey.
- Faculty of Pharmacy, Department of Pharmaceutical Technology, Acibadem Mehmet Ali Aydinlar University, 34752 Istanbul, Turkey.
- Faculty of Engineering and Natural Sciences, Department of Molecular Biology and Genetics, Acibadem Mehmet Ali Aydinlar University, 34752 Istanbul, Turkey.
ORCID-Profile: Aysegul Ekmekcioglu, Ozgul Gok, Meryem Sedef Erdal, Yasemin Yagan Uzuner, Meltem Muftuoglu
Förderung
- The Scientific and Technological Research Council of Turkey (TUBITAK)
- Scientific and Technological Research Council of Turkey (TUBITAK)
Zitieren
APA
Ekmekcioglu, A., Gok, O., Oz-Arslan, D., Erdal, M. S., Yagan Uzuner, Y., & Muftuoglu, M. (2024). Mitochondria-Targeted Liposomes for Drug Delivery to Tumor Mitochondria. Pharmaceutics, 16(7), 950. https://doi.org/10.3390/pharmaceutics16070950
Vancouver
Ekmekcioglu A, Gok O, Oz-Arslan D, Erdal MS, Yagan Uzuner Y, Muftuoglu M. Mitochondria-Targeted Liposomes for Drug Delivery to Tumor Mitochondria. Pharmaceutics. 2024;16(7):950. doi:10.3390/pharmaceutics16070950
BibTeX
@article{Ekmekcioglu2024,
author = {Ekmekcioglu, Aysegul and Gok, Ozgul and Oz-Arslan, Devrim and Erdal, Meryem Sedef and Yagan Uzuner, Yasemin and Muftuoglu, Meltem},
title = {Mitochondria-Targeted Liposomes for Drug Delivery to Tumor Mitochondria},
journal = {Pharmaceutics},
year = {2024},
volume = {16},
number = {7},
pages = {950},
doi = {10.3390/pharmaceutics16070950}
}
EUVIMED